From the author
J&J to spin off consumer products and focus on pharmaceuticals
"We think these have evolved as fundamentally different businesses," J&J CEO Alex Gorsky said.
Email Login
Premium
Only $39.95 per year- Quarterly magazine and digital
- Indepth executive interviews
- Unlimited news and insights
- Expert opinion and analysis
